← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2018Last known activity
Sep 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 9 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT07153744CollaboratorPhase 4Sep 1, 2025
- NCT06992128CollaboratorPhase 2May 22, 2025
- NCT06658834CollaboratorPhase 2Jun 1, 2024
- NCT06569108OfficialPhase 3Apr 1, 2024
- NCT06199089CollaboratorPhase 2Jan 16, 2024
- NCT06312475OfficialPhase 3Jan 9, 2024
- NCT05583838CollaboratorPhase 4Oct 31, 2022
- NCT04310865CollaboratorPhase 2/Phase 3Mar 20, 2020
- NCT03664518CollaboratorPhase 2Oct 1, 2018
Details
- Last known activity
- Sep 1, 2025